MTD
Mettler ToledoNYSEHealth CareDiagnostics & ResearchSnapshot 2026-05-08
As of May 8, 2026, MTD has a composite score of 21.8 and a confidence label of "medium," which reflects a change from "high." The score is influenced by various factors, including a favorable guidance credibility score of 100.0 and a macro score of 31.5, while the sector score is low at 7.6. The top drivers affecting the score include macroeconomic factors such as labor, rates, growth, and inflation.
Price
Daily closes from AlphaVantage. Earnings/event dots are placed inline.
Factor signals
Read top-to-bottom: thesis (is this a strong company over a 1–3 year hold), watch flags (has something changed worth re-reading), and position context (how violent might the path be). Each pill is a parallel diagnostic — never aggregated into a single score.
Thesis
— is this a strong company over a 1–3 year hold?Why this rank
- Direction share1.00
- Slope (norm)0.04
- Bonus0.00
Why this rank
Trailing four: 2024-Q1, 2024-Q2, 2024-Q3, 2025-Q3
Why this rank
Watch
— has something changed worth re-reading?Why this setup
EPS estimate $10.97 → $10.94 (-0.2% / 30d). 2 raised, 1 cut, 12 covering analysts.
0 upgrades, 0 downgrades / 30d, 1 maintained. 50% of analysts rate Buy.
1 PT revisions / 30d. Avg target 11.5% above current price.
0 positive, 0 negative / 30d.
F4 · Management deep-dive — recent events, stated priorities, guidance track record
Recent 8-K events
1 material event in the last 24 months — top 1 listed below.
Stated priorities
3 priorityies extracted from earnings transcripts (as of 2026-05-08).
- 1.Drive local currency sales growth of 4% in 2026growthmixed55% progress
5/7: “Management anticipates local currency sales will increase approximately 4% for 2026.”
Why this status
Stated in 3 of last 3 quarters. Local currency sales increased 3% in 2025, with regional growth of 5% in the Americas, 1% in Europe, and 2% in Asia/Rest of World. The trajectory shows limited progress towards the 4% target for 2026.
- 2.Achieve adjusted EPS growth of 8% to 10% in 2026growthmixed65% progress
5/7: “Adjusted EPS is forecast to be in the range of $46.30 to $46.95, representing growth of approximately 8% to 10%.”
Why this status
Stated in 3 of last 3 quarters. Adjusted EPS grew 4% in 2025, reaching $42.73 from $41.11 in 2024. The guidance for 2026 suggests a more ambitious growth target, but past performance shows moderate growth.
- 3.Expand Spinnaker sales and marketing programgrowthmixed65% progressprovisional
2/5: “We are very well positioned to drive growth with our Spinnaker sales and marketing program.”
Why this status
Newly stated in 2025-Q4. The Spinnaker program is highlighted as a growth driver, but no specific financial impact or milestones have been disclosed yet. The initiative's effectiveness remains to be seen.
Guidance track record
Last 7 quarters of EPS guidance with actuals.
Per-quarter detail
| Period | Guidance | Actual | Result |
|---|---|---|---|
| 2023-12-31 | — | 9.40 | unclassifiable |
| 2024-03-31 | $7.35 – $7.75 | $8.89 | beat |
| 2024-06-30 | $8.90 – $9.05 | $9.65 | beat |
| 2024-09-30 | $9.90 – $10.05 | $10.21 | beat |
| 2025-03-31 | $7.75 – $7.95 | $8.19 | beat |
| 2025-06-30 | $9.45 – $9.70 | $10.09 | beat |
| 2025-09-30 | $10.55 – $10.75 | $11.15 | beat |
Beat / inside / miss is computed from the guided range when issued; for point-estimate quarters a ±5% tolerance band around the mid is used. surprise_pct_vs_mid is unstable when guided EPS is near zero, so it is not surfaced as a headline.
Position context
— how violent might the path be while I hold it?Why this risk level
Recent vol — 30d annualized 56%; 252d 33%.
Drawdown — Max 1y −25%. Bad day move −3%.
Beta to sector ETF (XLV) — 1.20 over 1y.
Liquidity — score 100/100.
Sub-scores — vol 44/100, drawdown 49/100, beta 80/100, earnings vol —.
via XLV
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive — historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only — describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-05-08.
What changed
The most important moves since the prior daily snapshot.
- label change · confidence_labelseverity 20
Confidence changed from 'high' to 'medium'.
As of 2026-05-08, the confidence label for MTD changed from 'high' to 'medium'. This reflects a label change with a severity score of 20.0. Additionally, the forward view indicates an unfavorable scenario with a composite delta estimate of -8.0 if next-quarter guidance is cut. Other unfavorable scenarios include a -6.8 estimate if the labor state reverses from negative to positive, and a -5.0 estimate if the health care sector trend weakens.
as of 2026-05-08
Management scorecard
How management runs the business — capital, margins, balance sheet, and how reliably they guide and deliver.
Met or beat guidance 100% of the last 5 guided quarters · 4.9% avg surprise
What management is focused on
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
- #1
Drive local currency sales growth of 4% in 2026
GrowthNew since 2026-05-07Management aims for a 4% increase in local currency sales for the full year 2026.
MixedStated in 3 of last 3 quarters. Local currency sales increased 3% in 2025, with regional growth of 5% in the Americas, 1% in Europe, and 2% in Asia/Rest of World. The trajectory shows limited progress towards the 4% target for 2026.
55%CEO/CFO:“Management anticipates local currency sales will increase approximately 4% for 2026.”Multiple sourcesSource dated 2026-05-07Stated 3 of last 8 quartersFirst seen 2026-05-07Show history (3)
- 2026-Q1Multiple sources
“Management anticipates local currency sales will increase approximately 4%.”
- 2025-Q4Multiple sources
“Management anticipates local currency sales will increase approximately 4%.”
- 2025-Q3Multiple sources
“Management anticipates local currency sales growth of approximately 4% in 2026.”
- #2
Achieve adjusted EPS growth of 8% to 10% in 2026
GrowthNew since 2026-05-07Management forecasts adjusted EPS growth between 8% and 10% for the full year 2026.
MixedStated in 3 of last 3 quarters. Adjusted EPS grew 4% in 2025, reaching $42.73 from $41.11 in 2024. The guidance for 2026 suggests a more ambitious growth target, but past performance shows moderate growth.
65%CEO/CFO:“Adjusted EPS is forecast to be in the range of $46.30 to $46.95, representing growth of approximately 8% to 10%.”Multiple sourcesSource dated 2026-05-07Stated 3 of last 8 quartersFirst seen 2026-05-07Show history (3)
- 2026-Q1Multiple sources
“Adjusted EPS is forecast to be in the range of $46.30 to $46.95, representing growth of approximately 8% to 10%.”
- 2025-Q4Multiple sources
“Adjusted EPS is forecast to be in the range of $46.05 to $46.70, representing growth of approximately 8% to 9%.”
- 2025-Q3Multiple sources
“Adjusted EPS in the range of $45.35 to $46.00, representing growth of approximately 8% to 9%.”
- #3
Expand Spinnaker sales and marketing program
GrowthManagement plans to drive growth with the Spinnaker sales and marketing program.
MixedNewly stated in 2025-Q4. The Spinnaker program is highlighted as a growth driver, but no specific financial impact or milestones have been disclosed yet. The initiative's effectiveness remains to be seen.
65%CEO/CFO:“We are very well positioned to drive growth with our Spinnaker sales and marketing program.”Press releaseSource dated 2026-02-05Stated 1 of last 8 quartersFirst seen 2026-02-05provisionalShow history (1)
- 2025-Q4Press release
“We are very well positioned to drive growth with our Spinnaker sales and marketing program.”
How this stock is priced
Two ways to read price: against peers in the same business, and against the company's own history.
Looks more expensive than peers.
Cheaper than its own typical valuation.
P/E over the last 5 years
71 monthly pointsHow this compares
A side-by-side read on composite, valuation, and risk versus peers.
| Stock | Composite | Valuation | Risk |
|---|---|---|---|
MTD Mettler Toledo | +22 | full | moderate |
LLY Lilly (Eli) | +21 | full | moderate |
JNJ Johnson & Johnson | +18 | full | low |
ABBV AbbVie | +12 | fair | low |
UNH UnitedHealth Group | +24 | fair | elevated |
Risk — how this stock moves
What a normal day looks like, what a bad day looks like, and the worst the last year has thrown at it.
What could change this view
Conditional scenarios — if X happens, the score would shift by about Y points. These are not predictions.
- If health_care sector trend rises from +0.06 into 'improving' (>= +0.20)+5.0 pts
- If next-quarter guidance is raised (currently NEW as of 2026-05-07)+4.0 pts
- If next-quarter guidance is cut (currently NEW as of 2026-05-07)-8.0 pts
- If labor state reverses from -0.31 (negative) to +0.31 (positive)-6.8 pts
- If health_care sector trend falls from +0.06 into 'weakening' (<= -0.20)-5.0 pts
Material updates
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
- 2026-05-071d agoItem 2.02
Results of Operations and Financial Condition The following information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition.” The information furnished in this Form 8-K and the Exhibit attached hereto shall not be treated as filed for purposes of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. On May 7…
earnings preannouncement—score 64 - 2026-02-053mo agoItem 2.02
Results of Operations and Financial Condition The following information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition.” The information furnished in this Form 8-K and the Exhibit attached hereto shall not be treated as filed for purposes of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. On Febru…
earnings preannouncementneutralscore 8 - 2025-05-120y agoItem 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 8, 2025, the Compensation Committee of the Board of Directors of Mettler-Toledo International Inc. (the “Company”), with guidance from the Committee’s independent compensation consultant, approved the grant of 2025 long-term incentive (“LTI”) awards to the Company’s named executive officers (“NEOs”). The Committee approved a bifurcated grant…
executive changeneutralscore 0
Score history
The composite score, snapshot by snapshot. The dotted line at zero separates leaning-positive from leaning-negative.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.